Pharming Group (PHAR) Institutional Ownership $7.53 -0.23 (-2.96%) (As of 11/22/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Pharming Group (NASDAQ:PHAR)CurrentInstitutional OwnershipPercentage0.03%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$396.05KNumber ofInstitutional Sellers(last 12 months)0 Get PHAR Insider Trade Alerts Want to know when executives and insiders are buying or selling Pharming Group stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data PHAR Institutional Buying and Selling by Quarter Ad Chaikin AnalyticsNew post-election stock warning from Wall StreetIf you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first time in history...Not everything is as rosy as it seems on Wall Street. Pharming Group Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails10/5/2024 Silverberg Bernstein Capital Management LLC41,110$339K0.3%+75.4%0.061% 7/12/2024 Silverberg Bernstein Capital Management LLC23,435$196K0.2%+32.3%0.035% 1/17/2024 Silverberg Bernstein Capital Management LLC17,710$202K0.2%N/A0.026% 11/1/2023 Orion Portfolio Solutions LLC11,715$134K0.0%N/A0.018% 2/1/2023Cowen Prime Advisors LLC21,610$238K0.1%+29.4%0.033% 2/8/2022Cowen Prime Advisors LLC14,800$132K0.0%+134.9%0.023% 8/6/2021 JW Asset Management LLC169,225$1.91M0.4%-10.7%0.264% 8/4/2021Cowen Prime Advisors LLC6,300$71K0.0%N/A0.010% 5/12/2021 UBS Group AG2,508$32K0.0%+173.8%0.004% 2/5/2021 JW Asset Management LLC1,895,941$2.95M1.2%N/A2.971% (Data available from 1/1/2016 forward) PHAR Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PHAR shares? During the previous two years, the following institutional investors and hedge funds held shares of Pharming Group shares: Silverberg Bernstein Capital Management LLC ($339K), and Cowen Prime Advisors LLC ($238K), Orion Portfolio Solutions LLC ($134K).Learn more on PHAR's institutional investors. What percentage of Pharming Group stock is owned by institutional investors? 0.03% of Pharming Group stock is owned by institutional investors. Learn more on PHAR's institutional investor holdings. Which institutional investors have been buying Pharming Group stock? The following institutional investors have purchased Pharming Group stock in the last 24 months: Silverberg Bernstein Capital Management LLC ($41.11K), Orion Portfolio Solutions LLC ($11.72K), and Cowen Prime Advisors LLC ($4.91K). How much institutional buying is happening at Pharming Group? Institutional investors have bought a total of 57,735 shares in the last 24 months. This purchase volume represents approximately $583.76K in transactions. Related Companies MIRM Institutional Ownership CNTA Institutional Ownership SUPN Institutional Ownership MNKD Institutional Ownership EVO Institutional Ownership HRMY Institutional Ownership IRON Institutional Ownership NAMS Institutional Ownership GPCR Institutional Ownership ARVN Institutional Ownership This page (NASDAQ:PHAR) was last updated on 11/24/2024 by MarketBeat.com Staff From Our PartnersNew post-election stock warning from Wall StreetIf you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first ...Chaikin Analytics | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredA “Thank You Gift” From Pres. Trump - GeniusTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredPopular Stocks at Risk Under Trump—Are You Holding These?The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely ...StockEarnings | SponsoredAre Your Retirement Savings Really Safe?What They Don’t Want You to Know About Your 401(k)The 2008-2010 crisis wiped out almost 50% of the value of retirement funds. If you knew it was coming, wouldn'...American Hartford Gold | SponsoredDonald Trump can’t save you from this crisisElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | Sponsored#1 Crypto of 2024Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pharming Group Please log in to your account or sign up in order to add this asset to your watchlist. Share Pharming Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
